Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 138   

Articles published

GSK 1,411.28 -1.22 (-0.09%)
price chart
GlaxoSmithKline plc 15.6% Potential Upside Indicated by Barclays Capital
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' today by analysts at Barclays Capital.
Bremer Trust National Association Boosts Position in GlaxoSmithKline plc (GSK)  EMQ
Shares Of GlaxoSmithKline PLC (LON:GSK) Rated As Overweight By Analysts At ...  Risers & Fallers
Why GlaxoSmithKline plc, United Utilities Group PLC And Domino's Pizza Group ...
With the FTSE 100 coming under severe pressure due to concerns surrounding China, many investors are naturally seeking out safer stocks.
3 Safe High-Yield Stocks For Times Of Volatility: GlaxoSmithKline plc ...
Market volatility was a key theme for financial markets in 2015 and it looks like the road ahead for 2016 will most likely be more of the same.
GlaxoSmithKline plc 1% Potential Upside Suggested by Exane BNP Paribas
GlaxoSmithKline plc with EPIC/TICKER LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'NEUTRAL' this morning by analysts at Exane BNP Paribas.
BNP Paribas Reiterates "Neutral" Rating for GlaxoSmithKline plc (GSK)  Zolmax
Will GlaxoSmithKline plc (ADR) Provide A Cure For Synovial Sarcoma?
Adaptimmune Therapeutics plc - ADR (NASDAQ:ADAP) and GlaxoSmithKline plc (ADR) (NYSE:GSK) have announced their enhanced collaborative efforts toward the former's lead clinical cancer program.
Adaptimmune Therapeutics (ADAP), Glaxo (GSK) Expand Immunotherapy ...  StreetInsider.com
Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration  FierceBiotech
Shares Of GlaxoSmithKline PLC (LON:GSK) Rated As Hold By Analysts At Jefferies ...
According to an update released by analysts at Jefferies International the broker has now set a 'Hold' rating on shares of GlaxoSmithKline PLC (LON:GSK) with a price target of 1375. Jefferies International on Wednesday retained GlaxoSmithKline PLC's ...
GlaxoSmithKline plc (GSK) Issues Earnings Results, Meets Estimates  Daily Political
GlaxoSmithKline plc 13.3% Potential Upside Indicated by Deutsche Bank
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' this morning by analysts at Deutsche Bank.
JP Morgan Cazenove Maintains GBX 1390.00 Target Price On GlaxoSmithKline PLC ...  OctaFinance.com
GlaxoSmithKline plc's (GSK) "Market Perform" Rating Reiterated ...  Corvus Business Newswire
GlaxoSmithKline plc's (GSK) "Sell" Rating Reaffirmed at Societe Generale
GlaxoSmithKline plc logo Societe Generale reaffirmed their sell rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report report published on Thursday morning, AnalystRatings.
GlaxoSmithKline plc 19.3% Potential Upside Indicated by Barclays Capital
GlaxoSmithKline plc with EPIC/TICKER LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' today by analysts at Barclays Capital.
GlaxoSmithKline plc (GSK) Stake Raised by J. W. Burns & Company  EMQ
GlaxoSmithKline PLC (LON:GSK) Investors: Deutsche Bank Reconfirms Hold ...  OctaFinance.com
GlaxoSmithKline plc (ADR) Tops Revenue, Misses Core Earnings
GlaxoSmithKline plc (NYSE:GSK) stock gained approximately 4% during pre-market hours today, after the company disclosed financial results for fourth quarter of fiscal year 2015 (4QFY15) and fiscal year 2015 (FY15).